©No copyright
Orikine Bio secures €800k in innovation research funding to advance groundbreaking autoimmune disease therapy
©No copyright
Novadip’s NVDX3 reaches key milestones leading to IND approval from FDA to start phase 2b/3 study in cervical spine fusion
© Novadip
BiocSol secures €5.2M seed funding to transform sustainable crop protection with next generation microbial-based solutions, targeting total €10M in funding by year-end
©David Plas
DiogenX appoints Dr. Klara Owen as Chief Medical Officer
No copyright
Naobios and Sumagen successfully optimize HIV vaccine candidate for industrial production
©Naobios
Novadip reports promising interim results from its first-in-human proof-of-concept trial with NVDX3, a stem-cell derived bone graft alternative
©No copyright
Naobios and European Vaccine Initiative partner up to manufacture Respiratory Syncytial Virus (RSV) challenge agent
©Naobios
Eligo welcomes genetic medicines leader Bobby Gaspar as chair of its board of directors
©No copyright
Bio-Sourcing secures European Innovation Council (EIC) Accelerator funding to bridge the biomanufacturing gap and make biotherapeutics more available and affordable
No copyright